Prevalence and Characteristics of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia

References

1. 1.↵
   2. Shovlin CL

   . Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203–19 doi:10.1016/j.blre.2010.07.001 pmid:20870325

   CrossRefPubMedWeb of Science
2. 2.↵
   2. McDonald J,
   3. Bayrak-Toydemir P,
   4. Pyeritz RE

   . Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med 2011;13:607–16 doi:10.1097/GIM.0b013e3182136d32 pmid:21546842

   CrossRefPubMed
3. 3.↵
   2. McDonald J,
   3. Wooderchak-Donahue W,
   4. VanSant Webb C, et al

   . Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 2015;6:1 doi:10.3389/fgene.2015.00001 pmid:25674101

   CrossRefPubMed
4. 4.↵
   2. Jin Y,
   3. Muhl L,
   4. Burmakin M, et al

   . Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signaling. Nat Cell Biol 2017;19:639–52 doi:10.1038/ncb3534 pmid:28530660

   CrossRefPubMed
5. 5.↵
   2. Faughnan ME,
   3. Mager JJ,
   4. Hetts SW, et al

   . Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med 2020;173:989–1001 doi:10.7326/M20-1443 pmid:32894695

   CrossRefPubMed
6. 6.↵
   2. Shovlin CL,
   3. Guttmacher AE,
   4. Buscarini E, et al

   . Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–67 doi:10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P pmid:10751092

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Nishida T,
   3. Faughnan ME,
   4. Krings T, et al

   . Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. Am J Med Genet A 2012;158A:2829–34 doi:10.1002/ajmg.a.35622 pmid:22991266

   CrossRefPubMed
8. 8.↵
   2. Woodall MN,
   3. McGettigan M,
   4. Figueroa R, et al

   . Cerebral vascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2014;120:87–92 doi:10.3171/2013.10.JNS122402 pmid:24236651

   CrossRefPubMed
9. 9.↵
   2. Brinjikji W,
   3. Iyer VN,
   4. Sorenson T, et al

   . Cerebrovascular manifestations of hereditary hemorrhagic telangiectasia. Stroke 2015;46:3329–37 doi:10.1161/STROKEAHA.115.010984 pmid:26405205

   FREE Full Text
10. 10.↵
    2. Krings T,
    3. Kim H,
    4. Power S, et al

    ; Brain Vascular Malformation Consortium HHT Investigator Group. Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. AJNR Am J Neuroradiol 2015;36:863–70 doi:10.3174/ajnr.A4210 pmid:25572952

    Abstract/FREE Full Text
11. 11.↵
    2. Brinjikji W,
    3. Iyer VN,
    4. Yamaki V, et al

    . Neurovascular manifestations of hereditary hemorrhagic telangiectasia: a consecutive series of 376 patients during 15 years. AJNR Am J Neuroradiol 2016;37:1479–86 doi:10.3174/ajnr.A4762 pmid:27012295

    Abstract/FREE Full Text
12. 12.↵
    2. Gaetani E,
    3. Peppucci E,
    4. Agostini F, et al

    . Distribution of cerebrovascular phenotypes according to variants of the ENG and ACVRL1 genes in subjects with hereditary hemorrhagic telangiectasia. J Clin Med 2022;11:2685 doi:10.3390/jcm11102685 pmid:35628811

    CrossRefPubMed
13. 13.↵
    2. Ring NY,
    3. Latif MA,
    4. Hafezi-Nejad N, et al

    . Prevalence of and factors associated with arterial aneurysms in patients with hereditary hemorrhagic telangiectasia: 17-year retrospective series of 418 patients. J Vasc Interv Radiol 2021;32:1661–69 doi:10.1016/j.jvir.2021.08.018 pmid:34478850

    CrossRefPubMed
14. 14.↵
    2. Perez Akly MS,
    3. Vazquez C,
    4. Besada CH, et al

    . Prevalence of intracranial aneurysms in hereditary hemorrhagic telangiectasia: report from a single reference center. AJNR Am J Neuroradiol 2022;43:844–49 doi:10.3174/ajnr.A7505 pmid:35589139

    Abstract/FREE Full Text
15. 15.↵
    2. Akers AL,
    3. Ball KL,
    4. Clancy M, et al

    . Brain vascular malformation consortium: overview, progress and future directions. J Rare Disord 2013;1:5 pmid:25221778

    PubMed
16. 16.↵
    2. Krings T,
    3. Ozanne A,
    4. Chng SM, et al

    . Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years. Neuroradiology 2005;47:711–20 doi:10.1007/s00234-005-1390-8 pmid:16136265

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Fernandez Zubillaga A,
    3. Guglielmi G,
    4. Viñuela F, et al

    . Endovascular occlusion of intracranial aneurysms with electrically detachable coils: correlation of aneurysm neck size and treatment results. AJNR Am J Neuroradiol 1994;15:815–20 pmid:8059647

    Abstract/FREE Full Text
18. 18.↵
    2. Debrun GM,
    3. Aletich VA,
    4. Kehrli P, et al

    . Aneurysm geometry: an important criterion in selecting patients for Guglielmi detachable coiling. Neurol Med Chir (Tokyo) 1998;38(Suppl):1–20 doi:10.2176/nmc.38.suppl_1 pmid:10234971

    CrossRefPubMed
19. 19.↵
    2. Spetzler RF,
    3. Martin NA

    . A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–78 doi:10.3171/jns.1986.65.4.0476 pmid:3760956

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Rammos SK,
    3. Gardenghi B,
    4. Bortolotti C, et al

    . Aneurysms associated with brain arteriovenous malformations. AJNR Am J Neuroradiol 2016;37:1966–67 doi:10.3174/ajnr.A4869 pmid:27339951

    Abstract/FREE Full Text
21. 21.↵
    2. Thompson BG,
    3. Brown RD Jr.,
    4. Amin-Hanjani S, et al

    ; American Stroke Association. Guidelines for the management of patients with unruptured intracranial aneurysms: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:2368–400 doi:10.1161/STR.0000000000000070 pmid:26089327

    Abstract/FREE Full Text
22. 22.↵
    2. Hyldahl SJ,
    3. El-Jaji MQ,
    4. Schuster A, et al

    . Skin and mucosal telangiectatic lesions in hereditary hemorrhagic telangiectasia patients. Int J Dermatol 2022;61:1497–505 doi:10.1111/ijd.16320 pmid:35792874

    CrossRefPubMed
23. 23.↵
    2. Jaskolka J,
    3. Wu L,
    4. Chan RP, et al

    . Imaging of hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol 2004;183:307–14 doi:10.2214/ajr.183.2.1830307 pmid:15269017

    CrossRefPubMed
24. 24.↵
    2. Fish A,
    3. Henderson K,
    4. Moushey A, et al

    . Incidence of spontaneous pulmonary AVM rupture in HHT patients. J Clin Med 2021;10:4714 doi:10.3390/jcm10204714 pmid:34682838

    CrossRefPubMed
25. 25.↵
    2. Kilian A,
    3. Latino GA,
    4. White AJ, et al

    ; the Brain Vascular Malformation Consortium HHT Investigator Group. Genotype-phenotype correlations in children with HHT. J Clin Med 2020;9:2714 doi:10.3390/jcm9092714 pmid:32842615

    CrossRefPubMed
26. 26.↵
    2. Braverman IM,
    3. Keh A,
    4. Jacobson BS

    . Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990;95:422–27 doi:10.1111/1523-1747.ep12555569 pmid:2212727

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Crist AM,
    3. Lee AR,
    4. Patel NR, et al

    . Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of hereditary hemorrhagic telangiectasia. Angiogenesis 2018;21:363–80 doi:10.1007/s10456-018-9602-0 pmid:29460088

    CrossRefPubMed
28. 28.↵
    2. Bernabeu C,
    3. Bayrak-Toydemir P,
    4. McDonald J, et al

    . Potential second-hits in hereditary hemorrhagic telangiectasia. J Clin Med 2020;9:3571 doi:10.3390/jcm9113571 pmid:33167572

    CrossRefPubMed
29. 29.↵
    2. Singh E,
    3. Redgrave RE,
    4. Phillips HM, et al

    . Arterial endoglin does not protect against arteriovenous malformations. Angiogenesis 2020;23:559–66 doi:10.1007/s10456-020-09731-z pmid:32506200

    CrossRefPubMed
30. 30.↵
    2. Park H,
    3. Furtado J,
    4. Poulet M, et al

    . Defective flow-migration coupling causes arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 2021;144:805–22 doi:10.1161/CIRCULATIONAHA.120.053047 pmid:34182767

    CrossRefPubMed
31. 31.↵
    2. Moulinet T,
    3. Mohamed S,
    4. Deibener-Kaminsky J, et al

    . High prevalence of arterial aneurysms in hereditary hemorrhagic telangiectasia. Int J Cardiol 2014;176:1414–16 doi:10.1016/j.ijcard.2014.08.016 pmid:25150474

    CrossRefPubMed
32. 32.↵
    2. Krex D,
    3. Ziegler A,
    4. Schackert HK, et al

    . Lack of association between endoglin intron 7 insertion polymorphism and intracranial aneurysms in a white population: evidence of racial/ethnic differences. Stroke 2001;32:2689–94 doi:10.1161/hs1101.098660 pmid:11692035

    Abstract/FREE Full Text
33. 33.↵
    2. Onda H,
    3. Kasuya H,
    4. Yoneyama T, et al

    . Endoglin is not a major susceptibility gene for intracranial aneurysm among Japanese. Stroke 2003;34:1640–44 doi:10.1161/01.STR.0000075770.70554.99 pmid:12775886

    Abstract/FREE Full Text
34. 34.↵
    2. Santiago-Sim T,
    3. Mathew-Joseph S,
    4. Pannu H, et al

    . Sequencing of TGF-beta pathway genes in familial cases of intracranial aneurysm. Stroke 2009;40:1604–11 doi:10.1161/STROKEAHA.108.540245 pmid:19299629

    CrossRefPubMed
35. 35.↵
    2. van 't Hof FN,
    3. Ruigrok YM,
    4. Lee CH, et al

    ; Aneurysm Consortium; Vascular Research Consortium of New Zealand. Shared genetic risk factors of intracranial, abdominal, and thoracic aneurysms. J Am Heart Assoc 2016;5:e002603 doi:10.1161/JAHA.115.002603 pmid:27418160

    Abstract/FREE Full Text
36. 36.↵
    2. Alg VS,
    3. Sofat R,
    4. Houlden H, et al

    . Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology 2013;80:2154–65 doi:10.1212/WNL.0b013e318295d751 pmid:23733552

    Abstract/FREE Full Text
37. 37.↵
    2. Weir B,
    3. Disney L,
    4. Karrison T

    . Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients. J Neurosurg 2002;96:64–70 doi:10.3171/jns.2002.96.1.0064 pmid:11794606

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Backes D,
    3. Vergouwen MD,
    4. Tiel Groenestege AT, et al

    . PHASES score for prediction of intracranial aneurysm growth. Stroke 2015;46:1221–26 doi:10.1161/STROKEAHA.114.008198 pmid:25757900

    Abstract/FREE Full Text
39. 39.↵
    2. Helmchen C,
    3. Nahser HC,
    4. Yousry T, et al

    . Therapy of cerebral aneurysms and arteriovenous vascular malformations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) [in German]. Nervenarzt 1995;66:124–28 pmid:7715751

    PubMed
40. 40.↵
    2. Ishii D,
    3. Takechi A,
    4. Seyama G, et al

    . Ruptured large basilar artery aneurysm associated with an arteriovenous malformation in hereditary hemorrhagic telangiectasia. Neurol Med Chir (Tokyo) 2012;52:502–05 doi:10.2176/nmc.52.502 pmid:22850500

    CrossRefPubMed
41. 41.↵
    2. Gross BA,
    3. Du R

    . Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 2013;118:437–43 doi:10.3171/2012.10.JNS121280 pmid:23198804

    CrossRefPubMedWeb of Science
42. 42.↵
    2. Brinjikji W,
    3. Iyer VN,
    4. Wood CP, et al

    . Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg 2017;127:302–10 doi:10.3171/2016.7.JNS16847 pmid:27767404

    CrossRefPubMed